The company behind SystmOne has built a business around a simple promise: one patient, one record. Its most revealing results come from fixing the small administrative failures that make healthcare feel so disjointed.
Fifteen years of clinical history can make software hard to replace. From Welsh rheumatology clinics to Guyana’s national EHR project, RioMed’s Cellma shows why the patient record is only the beginning.
A badge tap looks trivial. Across 19 hospitals, it helped give clinicians back 49,057 hours a year - and turned a login utility into the wedge for a much larger identity business.
The company merged the market's two toughest rivals, built one operating system around the peculiar speed of urgent care, and now serves nearly half of America's clinics. Its real advantage is not a shinier chart - it is knowing exactly where a 20-minute visit gets stuck.
The Florida health-IT firm built a business around a stubborn idea: hospitals do not always need a new record system - they need the one they have to stop fighting the people who use it.
The Chicago health-tech company spent a decade trying to build the whole medical record. Then it kept the least glamorous piece - the dictionary - and turned that narrow wedge into a clinical-data business valued at more than $1.5 billion.
Two siblings built a chart for their father's clinic, then spent 16 years turning that family workaround into the operating system for independent primary care. The new wager is bigger: AI should finish the paperwork without hijacking the visit.
A basement-born medical software company went public, endured what its founder called a terrible ride, and sold for $121 million. Nearly four decades after launch, Medecision is betting that healthcare’s next breakthrough is not another dashboard - it is turning messy data into the next useful action.
The Mumbai-born company had accurate algorithms, willing pilot sites and almost no habitual users. Its climb from $113,000 in annual revenue to 45 million lives touched is a lesson in why clinical workflow - not clever code - decides whether healthcare AI matters.
Specialty drugs can be brilliant in the lab and maddening in real life. RxPx sells pharma companies one connected system for the paperwork, monitoring, coaching and human handoffs that determine whether a patient starts therapy - and stays on it.
The Vancouver medtech spent nearly a decade teaching an implant to report every step. Its more useful lesson came after launch: a stream of numbers is not a product until a care team knows what to do next.
Most clinical AI is trying to write the note. RhythmX AI wants to decide what deserves the doctor's attention next - and its merger with Get Well reveals why distribution may matter as much as the model.
Most pathology AI companies sell the clever answer. Gestalt sells the place where the slide, the case, the pathologist and competing algorithms can finally meet - a workflow-first bet backed by a $7.5 million Series A.
The New York venture studio has turned 14 health systems into a company-building network - giving young healthcare AI businesses something money alone cannot buy: trust, workflow access and a credible first customer.
Omnicell began with a father watching nurses hunt for supplies in a hospital. Three decades later, it is trying to make every medication drawer, robot and pharmacy workflow behave like one connected system.
Luminai is an AI-native workflow automation platform built for the back office of American healthcare. It turns messy, unstructured inputs - faxes, chart notes, insurance forms - into structured data and then runs full administrative workflows like referral intake, patient registration, and denial appeals end to end, with a human in the loop and HIPAA/SOC 2 controls baked in. Founded in 2019 by Kesava Kirupa Dinakaran and Dmitry Dolgopolov, the company started life as customer-support RPA tool DigitalBrain, pivoted entirely into healthcare, and raised a $38M Series B in April 2026 led by Peak XV Partners, with Cleveland Clinic as a flagship partner.

Hippocratic AI builds safety-focused generative AI agents for non-diagnostic, patient-facing clinical work - voice-based agents that handle care coordination, chronic disease check-ins, medication adherence, and patient education. Its Polaris constellation architecture coordinates dozens of specialized LLMs to keep conversations clinically safe, with humans escalating where needed.